R Mignani

Summary

Affiliation: Infermi Hospital
Country: Italy

Publications

  1. ncbi request reprint Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: a pilot study
    Renzo Mignani
    Department of Nephrology and Dialysis, Infermi Hospital, Rimini, Italy
    Kidney Int 65:1381-5. 2004
  2. ncbi request reprint Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications
    Renzo Mignani
    Department of Nephrology and Dialysis, Infermi Hospital, Rimini, Italy
    J Nephrol 17:354-63. 2004
  3. ncbi request reprint Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy
    Renzo Mignani
    Department of Nephrology and Dialysis, Infermi Hospital, Via Settembrini 2, 47900 Rimini, Italy
    Nephrol Dial Transplant 23:1628-35. 2008
  4. ncbi request reprint [Renal involvement in Fabry's disease: diagnosis, follow-up and enzyme replacement therapy]
    R Mignani
    U O Nefrologia e Dialisi, Ospedale degli Infermi, Rimini, Italy
    G Ital Nefrol 26:577-84. 2009
  5. doi request reprint Assessment of kidney volume in polycystic kidney disease using magnetic resonance imaging without contrast medium
    Renzo Mignani
    Nephrology and Dialysis Unit, Infermi Hospital, Rimini, Italy
    Am J Nephrol 33:176-84. 2011
  6. doi request reprint Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapy
    Renzo Mignani
    Department of Nephrology and Dialysis, Infermi Hospital, Rimini, Italy
    Clin J Am Soc Nephrol 5:379-85. 2010
  7. ncbi request reprint Chronic renal failure, dialysis, and renal transplantation in Anderson-Fabry disease
    Adalberto Sessa
    Department of Nephrology and Dialysis, Ospedale di Vimercate, Vimercate, Italy
    Semin Nephrol 24:532-6. 2004

Detail Information

Publications7

  1. ncbi request reprint Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: a pilot study
    Renzo Mignani
    Department of Nephrology and Dialysis, Infermi Hospital, Rimini, Italy
    Kidney Int 65:1381-5. 2004
    ..We sought to assess the safety and efficacy of enzyme replacement therapy (ERT) with recombinant human-alpha-galactosidase A (rh-alpha-Gal A) in kidney transplant recipients with Fabry disease, a previously unstudied population...
  2. ncbi request reprint Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications
    Renzo Mignani
    Department of Nephrology and Dialysis, Infermi Hospital, Rimini, Italy
    J Nephrol 17:354-63. 2004
    ..We reviewed the clinical trial observations, as well as subsequent clinical experiences with ERT in patients with Fabry's disease...
  3. ncbi request reprint Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy
    Renzo Mignani
    Department of Nephrology and Dialysis, Infermi Hospital, Via Settembrini 2, 47900 Rimini, Italy
    Nephrol Dial Transplant 23:1628-35. 2008
    ..A comprehensive Italian nationwide survey study was conducted to explore changes in cardiac status and renal allograft function in Fabry patients on renal replacement therapy (RRT) and enzyme replacement therapy (ERT)...
  4. ncbi request reprint [Renal involvement in Fabry's disease: diagnosis, follow-up and enzyme replacement therapy]
    R Mignani
    U O Nefrologia e Dialisi, Ospedale degli Infermi, Rimini, Italy
    G Ital Nefrol 26:577-84. 2009
    ..The aim of this study is also to provide recommendations regarding the diagnosis, follow-up and indication for enzyme replacement therapy in patients with Fabry's disease...
  5. doi request reprint Assessment of kidney volume in polycystic kidney disease using magnetic resonance imaging without contrast medium
    Renzo Mignani
    Nephrology and Dialysis Unit, Infermi Hospital, Rimini, Italy
    Am J Nephrol 33:176-84. 2011
    ..We developed a fast and nearly automated technique based on the analysis of MR images acquired without CM injection for TRV quantification...
  6. doi request reprint Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapy
    Renzo Mignani
    Department of Nephrology and Dialysis, Infermi Hospital, Rimini, Italy
    Clin J Am Soc Nephrol 5:379-85. 2010
    ..To clarify this issue, studies are needed to test the effectiveness of agalsidases in preventing cardiac and cerebrovascular complications in Fabry patients with ESRD...
  7. ncbi request reprint Chronic renal failure, dialysis, and renal transplantation in Anderson-Fabry disease
    Adalberto Sessa
    Department of Nephrology and Dialysis, Ospedale di Vimercate, Vimercate, Italy
    Semin Nephrol 24:532-6. 2004
    ....